Remdesivir and its antiviral activity against COVID-19: A systematic review
MetadataShow full item record
Background To summarize the antiviral activities of remdesivir against SARS-CoV-2, the causative agent of COVID-19. Methods Available publications were systematically explored on some databases and gray literature was examined. Publications were discussed narratively. Results Remdesivir inhibits SARS-CoV-2 replication, reduces viral load, and exerts protective effects in SARS-CoV-2 infected animals. Remdesivir also reduces the pathological process, alleviates mild symptoms, and improves pulmonary lesions in SARS-CoV-2-infecetd animals. Although remdesivir has been used as a compassionate drug for treating COVID-19 patients, it has only moderate efficacy. Conclusion Although remdesivir has shown potent antiviral activities, more efficacy assessments are urgently warranted in clinical trials.
Link to resourcehttps://doi.org/10.1016/j.cegh.2020.07.011
Estadísticas Google Analytics
Respuesta Comentario Repositorio Expeditio
Gracias por tomarse el tiempo para darnos su opinión.